Cardiovascular Systems INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$7.7Mgeneral payments (2019-2025)
$22Kresearch payments (2019-2025)
11,739clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Kevin Croce | Chestnut Hill, MA | Cardiovascular Disease | $193,722.58 |
| Peter Schneider | Honolulu, HI | Vascular Surgery | $130,734.42 |
| Jeffrey Chambers | Minneapolis, MN | Cardiovascular Disease | $119,008.87 |
| George Adams | Garner, NC | Interventional Cardiology | $118,690.93 |
| Jihad Mustapha | Grand Rapids, MI | Cardiovascular Disease | $114,315.25 |
| George Pliagas | Las Vegas, NV | Vascular Surgery | $96,980.64 |
| Douglas Drachman | Boston, MA | Interventional Cardiology | $95,257.99 |
| Paramjit Chopra | Hinsdale, IL | Vascular & Interventional Radiology | $92,618.71 |
| Julio Sanguily | West Palm Beach, FL | Vascular Surgery | $86,160.13 |
| David Kandzari | Atlanta, GA | Interventional Cardiology | $83,807.88 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.